Plants have natural products which use to possess antiproliferative potential against many cancers. In the present study, six isolated fractions (ethyl acetate, petroleum ether, chloroform, n-butanol, ethanol and aqueous) from Solanum nigrum were evaluated for their cytotoxic effect on different cell lines. Hepatic carcinoma cell line (HepG2), cervical cancer cell line (HeLa) and baby hamster kidney (BHK) used as normal non-cancerous cells were evaluated for cytotoxicity against isolated fractions. Cell viability assay was performed to evaluate the cytotoxicity of all fractions on different cell lines followed by the lactate dehydrogenase and vascular endothelial growth factor assays of most active fraction among all screened for cytotoxic analysis. HPLC analysis of most active fractions against cytotoxicity was performed to check the biological activity of compounds. Results displayed the potent cytotoxic activity of ethyl acetate fraction of S. nigrum against HepG2 cells with IC50 value of 7.89 μg/ml. Other fractions exhibited potent anticancer activity against HepG2 cells followed by HeLa cells. Fractions in our study showed no cytotoxicity in BHK cells. Cytotoxic activity observed in our current study exposed high antiproliferative potential and activity of ethyl acetate fraction against HepG2 cells. The results demonstrated that S. nigrum fractions exhibited anticancer activity against hepatic and cervical cancer cell lines with non-toxic effect in normal cells. These results reveal significant potential of S. nigrum for the therapeutic of cancers across the globe in future.
Iron deficiency diagnosis is a key health priority during pregnancy. The precise determination of indicators is needed for the evaluation of iron deficiency. In the present study, we investigated the diagnostic features of hepcidin concentration as an iron deficiency assay during the second trimester of pregnancy. We collected 401 venous blood samples of pregnant females from 4 separate birthing hospitals. All the females were within 13-26 weeks of their pregnancy and without any comorbid conditions. The complete blood count, total iron binding capacity, ferritin, serum iron and serum hepcidin were determined. The women were categorized as being non-iron deficient (N-ID), iron deficient (ID), or with iron deficiency anemia (IDA). The mean hepcidin values for examined groups were, i.e., non-iron deficiency was 31.45 +/- 4.70 (mu g/L), iron deficiency 20.47 +/- 2.48 (mu g/L) and iron deficiency anemia was 17.33 +/- 1.90 (mu g/L). The N-ID's hemoglobin mean levels were 13.05 +/- 0.10g/dL, ID 12.66 +/- 0.05g/dL and the IDA 8.11 +/- 00.12g/dL. In this article variations in hepcidin levels between N-ID, ID and IDA women are uncovered and it is reported that the lower hepcidin levels diagnosed in IDA are closely linked to hemoglobin in Pakistani women. Hence it is concluded that hepcidin can be a valuable marker in identifying iron deficiency and iron deficiency anemia during the second trimester of pregnancy, according to the Pearson's correlation data.
Hemochromatosis is an autosomal recessive iron overload disorder. The TFR2 gene variant rs7385804 has been implicated in hemochromatosis, but its role in the Pakistani population remains unexplored. This study intended to examine association of TFR2 gene variant rs7385804 with hemochromatosis in Pakistani individuals. We employed a case-control study design, recruiting 200 hemochromatosis patients and 200 healthy controls from Pakistani population. Deoxyribonucleic acid was isolated from blood samples using the phenol-chloroform method. Sanger sequencing and Tetra-ARMS PCR were used to identified the TFR2 genes and its variant rs7385804.Our results showed a significant association between TFR2 gene variant rs7385804 and hemochromatosis in Pakistani population (p < 0.001). The rate of the abnormal alleles was (35%) higher than control (15%). Sanger sequencing confirmed the presence of the variant in 70% of patients, while Tetra-ARMS PCR showed 90% concordance with sequencing results. This study demonstrates the utility of Sanger sequencing and Tetra-ARMS PCR in detecting TFR2 gene variant rs7385804 in Pakistani population. Our findings suggest that this variant may serve as a genetic marker for hemochromatosis in this population. More research is required to authorize these outcomes and discover the clinical consequences of this association.